SCHEMBL2827013

SCHEMBL2827013

CCOC(=O)c1ncsc1NCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
NPSR1 Q6W5P4 4/20 0.54
RAB9A P51151 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
GAA P10253 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
SMN1; SMN2 Q16637 5/20 0.52
EED O75530 1/20 0.50
ALDH1A1 P00352 6/20 0.49
MAPT P10636 4/20 0.49
LMNA P02545 4/20 0.49
CDC7 O00311 1/20 0.48
DBF4 Q9UBU7 1/20 0.48
ILK Q13418 1/20 0.47
KDM4E B2RXH2 2/20 0.46
HSD17B10 Q99714 1/20 0.46
HPGD P15428 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5169295 0.87 MAPT (0.62) MEN1KMT2ANPSR1RAB9ACYP1A2
SCHEMBL4902263 0.86 GAA (0.49) MEN1KMT2ARAB9AGAASMN1; SMN2
SCHEMBL2832760 0.82 TSHR (0.43) MEN1KMT2ARAB9ACYP1A2GAA
SCHEMBL2826673 0.82 KDM4E (0.52) KDM4E
SCHEMBL2827894 0.81 ILK (0.66) MEN1KMT2ANPSR1RAB9ACYP1A2
SCHEMBL2840279 0.78 NPSR1 (0.73) MEN1KMT2ANPSR1RAB9ACYP1A2
SCHEMBL2825669 0.77 TSHR (0.44) MEN1KMT2ANPSR1RAB9ACYP1A2
SCHEMBL4933312 0.77 ALOX5 (0.49) MEN1KMT2ANPSR1CYP1A2CYP3A4
SCHEMBL9295807 0.77 PDE5A (0.43) MEN1KMT2ANPSR1RAB9ACYP1A2
SCHEMBL2832151 0.77 MEN1 (0.43) MEN1KMT2ANPSR1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3008045-B1 ANTIBACTERIAL THIAZOLECARBOXYLIC ACIDS ANTABIO SAS (FR) 2018-05-09 EP disclosed
US-9914712-B2 Antibacterial thiazolecarboxylic acids ANTABIO SAS (FR) 2018-03-13 US disclosed
US-20160272601-A1 Antibacterial Thiazolecarboxylic Acids ANTABIO SAS (FR) 2016-09-22 US disclosed
WO-2014198849-A1 ANTIBACTERIAL THIAZOLECARBOXYLIC ACIDS ANTABIO SAS (FR) 2014-12-18 WO disclosed
EP-1844044-B1 THIAZOLE-4-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS HOFFMANN LA ROCHE (CH) 2010-07-21 EP disclosed
US-7678815-B2 Thiazole-4-carboxyamide derivatives HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US disclosed
EP-1844044-A1 THIAZOLE-4-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2007-10-17 EP disclosed
US-20060160857-A1 Thiazole-4-carboxyamide derivatives HOFFMANN-LA ROCHE INC. 2006-07-20 US disclosed
WO-2006074884-A1 THIAZOLE-4-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2006-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160857-A1 Thiazole-4-carboxyamide derivatives GRM1, GRM2, GRIA4 MEN1 2558/4885KMT2A 1012/4885NPSR1 173/4885
US-20160272601-A1 Antibacterial Thiazolecarboxylic Acids ME1, TALDO1, COASY MEN1 1657/4885KMT2A 1824/4885NPSR1 4204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.